Lantheus Holdings, Inc.
SEC Form 4 insider trading activity
Lantheus Holdings, Inc. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Lantheus Holdings, Inc. is listed as 10% Owner at Perspective Therapeutics, Inc. Inside the rolling window, Lantheus Holdings, Inc. reported no open-market purchases and 2 open-market sales totaling $357K in CATX. The largest disclosed transaction in the window is a sale of 78,145 CATX shares on Aug 31, 2026, worth $246K.
Companies traded
Other insiders at CATX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$357K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lantheus Holdings, Inc. made?
Lantheus Holdings, Inc. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Lantheus Holdings, Inc. trade?
Lantheus Holdings, Inc. has filed SEC Form 4 disclosures for 1 company, including CATX.
When was Lantheus Holdings, Inc.'s most recent SEC Form 4 filing?
Lantheus Holdings, Inc.'s most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Lantheus Holdings, Inc.'s total buy and sell value in the current window?
Inside the rolling retention window, Lantheus Holdings, Inc. bought $0 and sold $357K based on SEC Form 4 filings.
What was Lantheus Holdings, Inc.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 78,145 CATX shares on 2026-08-31, worth $246K, per SEC Form 4 filings.